Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.84−0.09 (-9.24%)
Close on Nov 20, 2026Market cap $146.37MP/E –Yield –
Palisade Bio free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Palisade Bio's free cash flow for the twelve months ending Dec 31, 2024 was -$12.19M. For fiscal 2024 it was -$12.19M. The highest annual figure on record is -$4.77M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$12.19M | – |
| FY2023 | Dec 31, 2023 | -$11.14M | – |
| FY2022 | Dec 31, 2022 | -$13.37M | – |
| FY2021 | Dec 31, 2021 | -$14.77M | – |
| FY2020 | Dec 31, 2020 | -$4.77M | – |
| FY2018 | Dec 31, 2018 | -$7.69M | – |
| FY2017 | Dec 31, 2017 | -$13.43M | – |
| FY2016 | Dec 31, 2016 | -$15.71M | – |
| FY2015 | Dec 31, 2015 | -$19.11M | – |
| FY2014 | Dec 31, 2014 | -$11.91M | – |
| FY2013 | Dec 31, 2013 | -$10.72M | – |
| FY2012 | Dec 31, 2012 | -$8.52M | – |
| FY2011 | Dec 31, 2011 | -$8.29M | – |
| FY2010 | Dec 31, 2010 | -$10.06M | – |
| FY2009 | Dec 31, 2009 | -$5.23M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$2.38M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.13M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.75M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.66M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.32M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.04M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.06M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.75M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.55M | – |
| Q3 FY2020 | Sep 30, 2020 | -$868.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.29M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.32M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.08M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.48M | – |
See a number that looks wrong?